174
Views
59
CrossRef citations to date
0
Altmetric
Original Research

Oleanolic acid liposomes with polyethylene glycol modification: promising antitumor drug delivery

, &
Pages 3517-3526 | Published online: 06 Jul 2012

References

  • TsurugaTChunYTEbizukaYSankawaUBiologically active constituents of Melaleuca leucadendron: inhibitors of induced histamine release from rat mast cellsChem Pharm Bull199139327632781726076
  • BalanehruSNagarajanBProtective effect of oleanolic acid and ursolic acid against lipid peroxidationBiochem Int1991249819901776961
  • ZhangYNZhangWHongDOleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B wth cellular activitiesBioorg Med Chem2008168697870518707891
  • ShibataSChemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compoundsJ Korean Med Sci200116SupplS283711748374
  • LiuJPharmacology of oleanolic acid and ursolic acidJ Ethnopharmacol19954957688847885
  • BilensoyEGurkaynakODoganALHincalAASafety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel deliveryInt J Pharm200834716317017689901
  • Arica YeginBBenoitJPLamprechtAPaclitaxel-loaded lipid nanoparticles prepared by solvent injection or ultrasound emulsificationDrug Dev Ind Pharm2006321089109417012121
  • TorchilinVPRecent advances with liposomes as pharmaceutical carriersNat Rev Drug Discov2005414516015688077
  • MosharrafMNystromCThe effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugsInt J Pharm19951223547
  • ElaineMMGaryGLDrug nanoparticles: formulating poorly water-soluble compoundsToxicol Pathol200836434818337220
  • NairHBSungBYadavVRKannappanRChaturvediMMAggarwalBBDelivery of anti-inflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancerBiochem Pharmacol2010801833184320654584
  • NaikSPatelDChuttaniKMishraAKMisraAIn vitro mechanistic study of cell death and in vivo performance evaluation of RGD grafted PEGylated docetaxel liposomes in breast cancerNanomedicine1122201110.1016/j.nano.2011.11.008
  • PapahadjopoulosDAllenTMGabizonASterically stabilized liposomes – improvements in pharmacokinetics and antitumor therapeutic efficacyProc Natl Acad Sci U S A19918811460114641763060
  • DrummondDCMeyerOHongKKirpotinDBPapahadjopoulosDOptimizing liposomes for delivery of chemotherapeutic agents to solid tumorsPharmacol Rev19995169174310581328
  • TakeuchiHKojimaHYamamotoHKawashimaYPassive targeting of doxorubicin with polymer coated liposomes in tumor bearing ratsBiol Pharm Bull20012479579911456120
  • SzokaFPapahadjopoulosDComparative properties and methods of preparation of lipid vesicles (liposomes)Annu Rev Biophys Bioeng198094675086994593
  • MishraBPatelBBTiwariSColloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug deliveryNanomedicine2010692419447208
  • AllenTMHansenCPharmacokinetics of stealth versus conventional liposomes: effect of doseBiochim Biophys Acta199110681331411911826
  • AllenTMHansenCMartinFRedemannCYau-YoungALiposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivoBiochim Biophys Acta1991106629362065067
  • GabizonAShmeedaHBarenholzYPharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studiesClin Pharmacokinet20034241943612739982
  • BistaKBruchRFCovingtonAMSorgerAGerstmannTOttoAInvestigations of thermotropic phase behavior of newly developed synthetic PEGylated lipids using Raman spectro-microscopyBiopolymers2008891012102018615661
  • SadzukaYKishiKHirotaSSonobeTEffect of polyethyleneglycol (PEG) chain on cell uptake of PEG-modified liposomesJ Liposome Res20031315717212855110
  • ShimadaKMatsuoSSadzukaYDetermination of incorporated amounts of poly(ethylene glycol)-derivatized lipids in liposomes for the physicochemical characterization of stealth liposomesInt J Pharmacol2000203255263
  • IshidaTHarashimaHKiwadaHLiposome clearanceBiosci Rep20022219722412428901
  • JustoORMoraesAMAnalysis of process parameters on the characteristics of liposomes prepared by ethanol injection with a view to process scale-up: effect of temperature and batch volumeChem Eng Res Des201189785792 (Chemical engineering research and design. ISSN:0263-8762)
  • JustoORMoraesAMKanamycin incorporation in lipid vesicles prepared by ethanol injection designed for tuberculosis treatmentJ Pharm Pharmacol200557233015638989
  • KrollAPillukatMHHahnDSchnekenburgerJCurrent in vitro methods in nanoparticle risk assessment: limitations and challengesEur J Pharm Biopharm20097237037718775492
  • PlumbJACell sensitivity assays: the MTT assayMethods Mol Med199928253021374024
  • KassimAEkarmul MahmudHNMYeeLMHanipahNElectrochemical preparation and characterization of polypyrrole-polyethylene glycol conducting polymer composite filmsPac J Sci Technol20067103107 (pdf)
  • PetrovaSMiloshevSMatevaRIlievISynthesis of amphiphilic PEG-PCL-PEG triblock copolymersJ Univ Chem Technol Metall200843199204 (pdf)
  • BlimeGCevcGLiposomes for the sustained drug release in vivoBiochim Biophys Acta1990102991972223816
  • KlibanovALMaruyamaKTorchilinVPHuangLAmphipathic poly(ethylene glycol) effectively prolong the circulation time of liposomesFEBS Lett19902682352372384160
  • FurumotoKYokoeJOgawaraKEffect of coupling of albumin onto surface of PEG liposome on its in vivo dispositionInt J Pharm200732911011617000067
  • ChenYJYangXLZhaoXLPreparation of oleanolic acid nanosuspensionJ Pharm Pharmacol200641924927
  • YangRSuLQHuangXPreparation and quality evaluation of oleanolic acid self-microemulsionFood Drug2008104042 Chinese literature
  • TangFLiHDDispersion of oleanolic acid drop pills and its evaluation in vitroChin Pharm J20084311671169 Chinese literature
  • QuellecPGrefRPerrinLProtein encapsulation within polyethylene glycol-coated nanospheres. I. Physicochemical characterizationJ Biomed Mater Res19984245549740006
  • ShimadaKMiyagishimaASadzukaYDetermination of the thickness of the fixed aqueous layer around polyethyleneglycol-coated liposomesJ Drug Target199532832898821002
  • SadzukaYNakadeAHiramaREffect of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposomeInt J Pharm200223817118011996821
  • ShehataTOgawaraKHigakiKKimuraTProlongation of residence time of liposome by surface-modification with mixture of hydrophilic polymersInt J Pharm200835927227918486370
  • YokoeJSakuragiSYamamotoKAlbumin-conjugated PEG liposome enhances tumor distribution of liposomal doxorubicin in ratsInt J Pharm2008353283418082345
  • MatteucciMLThrallDEThe role of liposomes in drug delivery and diagnostic imaging: a reviewVet Radiol Ultrasound20004110010710779068
  • Pedroso de LimaMCNevesSFilipeADuzgunesNSimoesSCationic liposomes for gene delivery: from biophysics to biological applicationsCurr Med Chem2003101221123112678796
  • Bakker WoudenbergIAStormGWoodleMCLiposomes in the treatment of infectionsJ Drug Target199423633717704480
  • ShengYLiuCYuanYLong-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosanBiomaterials2009302340234819150737
  • ZahrASDavisCAPishkoMVMacrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol)Langmuir2006228178818516952259
  • GbadamosiJKHunterACMoghimiSMPEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performanceFEBS Lett200253233834412482589
  • PapisovMITheoretical considerations of RES-avoiding liposomes: molecular mechanics and chemistry of liposome interactionsAdv Drug Deliv Rev19983211913810837639
  • PrievASamuniATiroshOBarenholzYThe role of hydration in stabilization of liposomes: resistance to oxidative damage of PEG-grafted liposomesJ Target Drug19986147167
  • TiroshOBarenholzYKatzhendlerJPrievAHydration of polyethylene glycol-grafted liposomesJ Biophys19987413711379
  • ZalipskySHarrisMJChemistry and biological applications of poly(ethylene glycol)Presented at ACS Symposium Series 680April 13–17, 1997San Francisco, CA
  • ZuckerDAndriyanovAVSteinerARavivUBarenholzYCharacterization of PEGylated nanoliposomes co-remotely loaded with topotecan and vincristine: relating structure and pharmacokinetics to therapeutic efficacyJ Control Release1012201110.1016/j.jconrel.2011.10.003
  • KaminskasLMMcLeodVMKellyBDA comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimerNanomedicine2012810311121704192
  • BrusaPArpiccoSStellaBDosioFCattelLImmordinoMLPreparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxelJ Control Release20039141742912932719
  • NaikSPatelDSurtiNMisraAPreparation of PEGylated liposomes of docetaxel using supercritical fluid technologyJ Supercrit Fluids201054110119
  • DadashzadehSMirahmadiNBabaeiMHValiAMPeritoneal retention of liposomes: effects of lipid composition, PEG coating and liposome chargeJ Control Release201014817718620800629